Suchergebnisse - "Hong, David S"

PubPharm (604)

1

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors

enthalten in: The oncologist | 2024

von Piha-Paul, S. | Xu, B. | Dumbrava, E. | +22

2

Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Hong, D. | Cappuzzo, F. | Chul Cho, B. | +11

3

Hybridizing mechanistic mathematical modeling with deep learning methods to predict individual cancer patient survival after immune checkpoint inhibitor therapy

enthalten in: Research square | 2024

von Butner, J. | Dogra, P. | Chung, C. | +5

4

Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment

enthalten in: Cancer treatment reviews | 2024

von Li Sucholeiki, R. | Propst, C. | Hong, D. | +1

5

Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies

enthalten in: Cancer research communications | 2024

von Subbiah, V. | Coleman, N. | Piha-Paul, S. | +15

6

Open RT Structures : A Solution for TG-263 Accessibility

enthalten in: International journal of radiation oncology, biology, physics | 2024

von Anderson, B. | Padilla, L. | Ryckman, J. | +8

7

Identifying a stable and generalizable factor structure of major depressive disorder across three large longitudinal cohorts

enthalten in: Psychiatry research | 2024

von Tseng, V. | Tharp, J. | Reiter, J. | +105

8

Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration

enthalten in: JCI insight | 2024

von Liu, A. | Gammon, S. | Pisaneschi, F. | +5

9

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies

enthalten in: Oncoimmunology | 2024

von Lin, C. | Garralda, E. | Schöffski, P. | +27

10

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer : a phase 1b trial

enthalten in: Nature medicine | 2024

von Kuboki, Y. | Fakih, M. | Strickler, J. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[61]